BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 23614467)

  • 1. Congenital nasolacrimal duct obstruction in premature children.
    Lorena SH; Silva JA; Scarpi MJ
    J Pediatr Ophthalmol Strabismus; 2013; 50(4):239-44. PubMed ID: 23614467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and clinical characteristics of congenital nasolacrimal duct obstruction.
    Sathiamoorthi S; Frank RD; Mohney BG
    Br J Ophthalmol; 2019 Apr; 103(4):527-529. PubMed ID: 29875230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal dacryostenosis as a risk factor for anisometropia.
    Piotrowski JT; Diehl NN; Mohney BG
    Arch Ophthalmol; 2010 Sep; 128(9):1166-9. PubMed ID: 20837801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between congenital nasolacrimal duct obstruction and mode of delivery at birth.
    Tavakoli M; Osigian CJ; Saksiriwutto P; Reyes-Capo DP; Choi CJ; Vanner EA; Cavuoto KM; Wester ST
    J AAPOS; 2018 Oct; 22(5):381-385. PubMed ID: 30243932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Congenital nasolacrimal duct obstruction in Japanese infants: its incidence and treatment with massage.
    Noda S; Hayasaka S; Setogawa T
    J Pediatr Ophthalmol Strabismus; 1991; 28(1):20-2. PubMed ID: 2019953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Factors affected therapeutic results in treatment of children congenital nasolacrimal duct obstruction by Ritleng lacrimal intubation].
    Yu G; Hu M; Wu Q; Cao WH; Fan YW; Lin Q; Liu W
    Zhonghua Yan Ke Za Zhi; 2012 May; 48(5):423-7. PubMed ID: 22932332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spontaneous Resolution and Timing of Intervention in Congenital Nasolacrimal Duct Obstruction.
    Sathiamoorthi S; Frank RD; Mohney BG
    JAMA Ophthalmol; 2018 Nov; 136(11):1281-1286. PubMed ID: 30178001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Success of probing for congenital nasolacrimal duct obstruction in children under 10 years of age.
    Thongthong K; Singha P; Liabsuetrakul T
    J Med Assoc Thai; 2009 Dec; 92(12):1646-50. PubMed ID: 20043568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The results of late probing in congenital nasolacrimal duct obstruction.
    Zilelioğlu G; Hoşal BM
    Orbit; 2007 Mar; 26(1):1-3. PubMed ID: 17510863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amblyopia Risk Factors in Newborns With Congenital Nasolacrimal Duct Obstruction.
    Vagge A; Tulumello C; Pellegrini M; Di Maita M; Iester M; Traverso CE
    J Pediatr Ophthalmol Strabismus; 2020 Jan; 57(1):39-43. PubMed ID: 31972039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The incidence of pediatric dacryocystitis among a population-based cohort of infants with congenital nasolacrimal duct obstruction.
    Ashby G; Sathiamoorthi S; Mohney BG
    J AAPOS; 2024 Jun; 28(3):103928. PubMed ID: 38704019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nasolacrimal duct office probing in children under the age of 12 months: Cure rate and cost evaluation.
    Le Garrec J; Abadie-Koebele C; Parienti JJ; Molgat Y; Degoumois A; Mouriaux F
    J Fr Ophtalmol; 2016 Feb; 39(2):171-7. PubMed ID: 26826746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Success rates of dacryoendoscopy-guided probing for recalcitrant congenital nasolacrimal duct obstruction.
    Fujimoto M; Ogino K; Matsuyama H; Miyazaki C
    Jpn J Ophthalmol; 2016 Jul; 60(4):274-9. PubMed ID: 27116947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Lacrimal Sac Massage in Management of Congenital Nasolacrimal Duct Obstruction in Infants: An Observational Study of 853 Cases from a Single Institute of Eastern Asia.
    Nanda D; Sarkar M
    Middle East Afr J Ophthalmol; 2022; 29(4):216-219. PubMed ID: 38162564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anisometropia and Refractive Status in Children with Bilateral Congenital Nasolacrimal Duct Obstruction.
    Siddiqui SN; Hannan A; Mansoor H; Asif M; Wakeel U
    J Coll Physicians Surg Pak; 2018 Mar; 28(3):210-213. PubMed ID: 29544578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of probing under topical anesthesia in children below 18 months of age with congenital nasolacrimal duct obstruction.
    Shrestha JB; Bajimaya S; Hennig A
    Nepal Med Coll J; 2009 Mar; 11(1):46-9. PubMed ID: 19769238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The natural process of congenital nasolacrimal duct obstruction and effect of lacrimal sac massage.
    Karti O; Karahan E; Acan D; Kusbeci T
    Int Ophthalmol; 2016 Dec; 36(6):845-849. PubMed ID: 26948127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of primary monocanalicularnasal intubation with Monoka tubes and nasal endoscopic findings for congenital nasolacrimal duct obstruction with enlarged lacrimal sac and chronic dacryocystitis.
    Lee H; Ahn J; Shin HH; Park M; Baek S
    J Craniofac Surg; 2012 Nov; 23(6):1638-41. PubMed ID: 23147293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical effectiveness of monocanalicular and bicanalicular silicone intubation for congenital nasolacrimal duct obstruction.
    Lee H; Ahn J; Lee JM; Park M; Baek S
    J Craniofac Surg; 2012 Jul; 23(4):1010-4. PubMed ID: 22777434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Spontaneous resolving rate of congenital nasolacrimal duct obstruction and success rate of late probing after age 18 months: historical cohort study].
    Hayashi K; Katori N; Komatsu H; Ohno-Matsui K
    Nippon Ganka Gakkai Zasshi; 2014 Feb; 118(2):91-7. PubMed ID: 24640789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.